U.S. Patent Disclosures
Friday, July 12, 2013
Celldex Therapeutics Inc., of Needham, Mass., was issued U.S. Patent No. 8,481,029, "Human immune therapies using a CD27 agonist alone or in combination with other immune modulators." The patent covers its product candidate CDX-1127.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.